Annual Scientific Meeting 2012
Welcome Speech
Prof. James CS Chim, University of Hong Kong, Hong Kong
Clinical use of Immunoglobulin Heavy/light chains in diagnosis and monitoring of multiple myeloma
Dr. Eric Chan, Queen Mary Hospital, Hong Kong
Added Value of 11C-acetate PET/CT to 18F-FDG for the diagnosis and Management of Multiple Myeloma
Dr. Garrett Ho, Hong Kong Sanatorium & Hospital, Hong Kong
Bench to Bedside Translation of Targeted Therapeutics in Multiple Myeloma
Dr. Kenneth C. Anderson, Dana Faber Cancer Institute, USA
Team Break
Transplantation in Myeloma
Prof. Huang Xiaojun, Peking University Institute of Hematology, China
Myeloma in Thailand, the Thai Myeloma Working Group
Dr. Weerasak Nawarawong, Chiang Mai University, Thailand
Frontline treatment for MM in Taiwan – Targeting on novel agents
Dr. Jeffrey Huang, National Taiwan University, Taiwan
Early results of Korean observation study of VMP or lenalidomide for relapsed or refractory MM in Korea
Dr. Kihyun Kim, Samsung Medical Center, Korea
European Perspectives on Frontline Multiple Myeloma Treatment
Prof. Mario Boccadoro, Universita degli Studi di Torino, Italy
Combined Q&A for Session II
Closing Remark
Prof. James CS Chim, University of Hong Kong, Hong Kong
Dinner

Dana Faber Cancer Insitiute, Harvard University
Queen Mary Hospital
Hong Kong Sanatorium

Peking University

National Taiwan University

Samsung University

Thai Society of Myeloma